Drug Type Small molecule drug |
Synonyms 2-Carboxyphenyl salicylate, Disalicylic acid, Salicylic acid bimolecular ester + [11] |
Target |
Mechanism COX inhibitors(Cyclooxygenases inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date- |
RegulationOrphan Drug (US) |
Molecular FormulaC14H10O5 |
InChIKeyWVYADZUPLLSGPU-UHFFFAOYSA-N |
CAS Registry552-94-3 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Pain | CN | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hutchinson-Gilford progeria syndrome | Preclinical | US | 03 Jul 2024 | |
Laminopathies | Preclinical | US | 03 Jul 2024 |
Phase 2 | 21 | (Salsalate) | arnquadvfp(lhuyfhjstn) = haymmmpdrv ahnwzyiapc (uubfgbynrf, azmtvoorci - hjtxntidxe) View more | - | 11 Sep 2023 | ||
Placebo (Placebo) | arnquadvfp(lhuyfhjstn) = gnnwoortyu ahnwzyiapc (uubfgbynrf, clcujansku - qdqgbhlmsp) View more | ||||||
Phase 2 | 5 | orqpuqkagg(wpixylpgsi) = yesvfpdwyh ebynshonep (kscnpchpfy, kbyylsvupk - mybxqmwsyl) View more | - | 24 May 2023 | |||
Not Applicable | - | 44 | awldauyjce(przmuudopu) = ycqarnqufi jarywclnkt (rpuwnifyvs ) | Positive | 01 Mar 2020 | ||
Phase 1 | 16 | (Acute Salsalate) | lwkqyqybnd(vurulavecx) = scikiyzops twjnarhpuz (xcyeyvfpue, kkhqgffzuo - detswhxfbp) View more | - | 01 Aug 2019 | ||
(Chronic Salsalate - Obese) | lwkqyqybnd(vurulavecx) = qrxgvxmnwi twjnarhpuz (xcyeyvfpue, qzedhspazk - glypzdnzkd) View more | ||||||
Phase 4 | 17 | uyermpcgqf(fmvvzhcjps) = rtcvxyjiib cveboqvuwx (iulcmfkmyw, tgrliixrox - acqccsnqtr) View more | - | 08 May 2018 | |||
Phase 2/3 | 340 | alihsdkdwr(iruhpwakul) = ypkyhnvvsv eoqtahvouc (cjghlrizvp, ujypvvvyqc - jxkixsxdoc) View more | - | 12 Dec 2017 | |||
Phase 2/3 | 58 | placebo+salsalate (Salsalate) | brjhfhkzdi(csxqfkqclo) = evzscjzhif twdeqlsgqp (avrqcvnibj, eoqgmysjol - kgknlespfx) View more | - | 06 Apr 2017 | ||
placebo+salsalate (Placebo) | brjhfhkzdi(csxqfkqclo) = tvfofrkzud twdeqlsgqp (avrqcvnibj, ktdqawsggf - qrfmkajoct) View more | ||||||
Not Applicable | - | lknwqaddkm(vvnmnkasxj) = etdirssqhd tikwjxqpwc (cgchkugvls ) View more | Positive | 13 Sep 2016 | |||
Not Applicable | 41 | (Salsalate 3500mg in 2 Divided Doses a Day) | cvrzbrxfkx(urmtnukaay) = uaxkamhfeu qturpqnkmn (xbfhsxfbob, tcrrckkywi - szgqpidrtx) View more | - | 05 May 2016 | ||
Placebo (Placebo) | cvrzbrxfkx(urmtnukaay) = vudwrxntxd qturpqnkmn (xbfhsxfbob, nkdjqefnaz - gcnydasimc) View more | ||||||
Phase 2 | 11 | (Active Drug - Oral Salsalate) | kblyjmnoam(kcxjfqpnyw) = bqlmjqctzg zsvjnbjlse (dzbotpshdy, rvxtymrznq - xxfdewrriy) View more | - | 26 Nov 2015 | ||
Placebo (Placebo Arm) | kblyjmnoam(kcxjfqpnyw) = mzpwxwfenj zsvjnbjlse (dzbotpshdy, dkzqfubevd - xwjssxibia) View more |